C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/337 (2006.01)
Patent
CA 2647579
Method for predicting the survival of a patient suffering from NSCLC to an antimicrotubule agent based chemotherapy treatment which comprises the step of determining the methylation state of a nucleic acid encoding CHFR in a biological sample from the patient, wherein the presence of methylation is indicative of longer survival of said patient as a response to said chemotherapy treatment. The methylation status of the CHFR gene can be easily determined in a serum sample.
L'invention concerne une méthode pour prédire la survie d'un patient souffrant d'un NSCLC à un traitement par chimiothérapie à base d'un agent anti-microtubule, qui consiste à déterminer l'état de méthylation d'un acide nucléique codant CHFR dans un échantillon biologique dudit patient, la présence d'une méthylation étant indicatrice d'une survie plus longue dudit patient, en réponse à ce traitement par chimiothérapie. L'état de méthylation du gène CHFR peut être facilement déterminé dans un échantillon de sérum.
Costa Rafael Rosell
Taron Roca Miguel
Fetherstonhaugh & Co.
Pangaea Biotech S.a.
LandOfFree
Method of predicting survival of a non-small-cell lung... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of predicting survival of a non-small-cell lung..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of predicting survival of a non-small-cell lung... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1958290